Linked Life Data

16396754

Source:http://linkedlifedata.com/resource/pubmed/id/16396754

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2006-1-6
pubmed:abstractText
Non metastatic adenocarcinoma of prostate can be cured in the vast majority of cases with surgery and/or external or interstitial radiotherapy. Failures are much more frequent when tumours are locally advanced. For this reason, new strategies have been designed, among them combined radiotherapy and hormonotherapy, in most cases with a LHRH analog, neoadjuvant and/or concomitant and/or adjuvant. Analysis of results of recent randomised trials comparing this association and exclusive radiotherapy allows for validating concept of combined radiotherapy and hormono therapy in locally advanced adenocarcinoma of prostate, while many questions should be more clearly answered.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1769-6917
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
92
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1078-84
pubmed:dateRevised
2011-4-5
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
[Combined radiotherapy and hormone therapy in non metastatic adenocarcinoma of prostate].
pubmed:affiliation
Service de radiothérapie oncologique, Groupe hospitalier Pitié-Salpêtrière, AP-HP, 47-83, Boulevard de l'Hôpital, 75651 Paris cedex 13. jean-Jacques.mazeron@psl.aphp.fr
pubmed:publicationType
Journal Article, English Abstract